4
Changes in Ownership
Vaxcyte, Inc. Filed Acc 0001649094-25-000002
CHIEF OPERATING OFFICER sold 8,000 shares at an average $83.66 ($669,267)
- CHIEF OPERATING OFFICER acquired 8,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Wassil Jim CHIEF OPERATING OFFICER | 2025-01-02 | Option exercise 10b5-1 | +8,000 | $2.42 | $19,360 | 213,695 | D |
| Wassil Jim CHIEF OPERATING OFFICER | 2025-01-02 | Sale 10b5-1 | −1,356 | $82.88 | $112,381 | 212,339 | D |
| Wassil Jim CHIEF OPERATING OFFICER | 2025-01-02 | Sale 10b5-1 | −5,483 | $83.69 | $458,861 | 206,856 | D |
| Wassil Jim CHIEF OPERATING OFFICER | 2025-01-02 | Sale 10b5-1 | −1,161 | $84.43 | $98,024 | 205,695 | D |
| Derivatives | |||||||
| Wassil Jim CHIEF OPERATING OFFICER | 2025-01-02 | Option exercise · Stock Option (right to buy) 10b5-1 | −8,000 | 10,638 | D | ||
| Open-market sales · 8,000 sh · avg $83.66 · $669,267 | |||||||
Loading xslF345X05/wk-form4_1735945636.xml…